Loading...
Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer
Colorectal cancer (CRC) is a leading cause of cancer deaths. Molecularly targeted therapies (e.g. bevacizumab) have improved survival rates but drug resistance ultimately develops and newer therapies are required. We identified quininib as a small molecule drug with anti-angiogenic activity using in...
Na minha lista:
| Udgivet i: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5064353/ https://ncbi.nlm.nih.gov/pubmed/27739445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep34523 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|